Mala Murthy - 01 Jun 2022 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role: CHIEF FINANCIAL OFFICER
Signature: /s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol: TDOC
Transactions as of: 01 Jun 2022
Net transactions value: $0
Form type: 4
Filing time: 03 Jun 2022, 16:14:54 UTC
Previous filing: 16 May 2022
Next filing: 28 Jun 2022
SEC: View on sec.gov

Quoteable Key Fact

"Mala Murthy filed Form 4 for Teladoc Health, Inc. (TDOC) on 03 Jun 2022."

Quick Takeaways

This page summarizes Mala Murthy's Form 4 filing for Teladoc Health, Inc. (TDOC).
2 reported transactions and 2 derivative rows are listed below.
Filing timestamp: 03 Jun 2022, 16:14.

What Changed

Previous filing in this sequence was filed on 16 May 2022.
Current net transaction value: $0.

Why This Matters

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Source Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TDOC	Employee Stock Option (right to buy)	Award	$0	+141,076		$0.000000	141,076	01 Jun 2022	Common Stock	141,076	$32.62	Direct	F1
transaction	TDOC	Restricted Stock Units	Award	$0	+24,525		$0.000000	24,525	01 Jun 2022	Common Stock	24,525		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option will vest as to one-third of the shares on June 1, 2023. The remainder of the shares will vest in 24 substantially equal monthly installments thereafter.
F2	Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F3	One-third of the restricted stock units vest on June 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .